Results 41 to 50 of about 252,158 (241)

Modified Completion Test (MCT) in Psychological Diagnostics of Patients with Paranoid Schizophrenia — Stage of Filling the Gaps

European Psychiatry, 2022
Introduction The study demonstrates potential of the modified completion test (MCT) (text by H. Ebbinghaus) for diagnostics of patients with schizophrenia.
N. Burlakova
doaj   +1 more source

Is Praecox Feeling at risk of extinction?

European Psychiatry, 2022
Introduction Praecox feeling (PF) is a characteristic feeling of bizarreness or unease that a psychiatrist experiences when facing a patient with schizophrenia. This term, proposed by Rumke in 1941, was considered an important feature of a schizophrenia
A. Duarte, C. Laginhas, A. Lourenço, I. Simões, P. Martins   +4 more
doaj   +1 more source

Combination of clozapine, cariprazine and fluoxetine in treatment-resistant schizophrenia patient with prominent negative symptoms: A Case report

European Psychiatry, 2022
Introduction Despite pharmacological advances in the treatment of schizophrenia, significant number of patients are still treatment-resistant. Clozapine is recommended as first-line treatment for treatment-resistant schizophrenia (TRS) in guidelines ...
I. Everte, A. Pamše-Romāne, M. Taube
doaj   +1 more source

“Anorexia in a patient with piscosis”

European Psychiatry, 2021
Introduction We present the case of a patient with schizophrenia who presents with restriction of intake, fear of gaining weight and alteration in the way of perceiving herself in which we ask ourselves if these behavioral alterations are secondary to ...
C. Capella Meseguer, E. Rodríguez Vázquez, J. Gonçalves Cerejeira, I. Santos Carrasco, A. Gonzaga Ramírez, G. Guerra Valera, M. Queipo De Llano De La Viuda, Ó. Martín   +7 more
doaj   +1 more source

First Episode Psychosis and intensity of care after discharge : difference at two years between lost and maintained follow-up patients

European Psychiatry, 2022
Introduction Disengagement from care in early psychosis is frequent. In outpatient general psychiatric services rates range from 17 % to 60 %. In early intervention programs, rates range from 14 % to 33 % at two years.
R. Bordas, E. Laffont, C. Jourdan, M. Pujol, L. Lamary   +4 more
doaj   +1 more source

Success rates of smoking cessation therapies to patients with mental illness by video consultants or by treatment in the community: A Randomized Controlled Trial

European Psychiatry, 2022
Introduction Smoking is probably the one single factor with the highest impact on reducing the life expectancies of patients with mental illness. In Denmark, 38.8% of patients with persistent mental health problem are smoking.
M.K. Sorensen, M. Rasmussen, P. Hjorth, R. Christiansen   +3 more
doaj   +1 more source

Title: Haematological disorders revealing a raticide suicide attempt: A case report

European Psychiatry, 2021
Introduction Suicide attempts are common in individuals with schizophrenia. These actions are marked by a greater lethality, due to the use of more violent means in particular the intentional ingestion of rodenticides.
N. Messedi, W. Abid, I. Krichen, I. Frikha, R. Ouali, N. Halouani, C. Kallel, J. Aloulou   +7 more
doaj   +1 more source

Mental Disorders [PDF]

, 2021
This book brings together an international array of stars of the mental health professions to create a cutting edge volume that sheds light on many important and heretofore poorly understood issues in psychopathology.

core   +1 more source

Green space and schizophrenia: A review

European Psychiatry, 2021
Introduction Urban living has consistently been associated with higher risk of developing schizophrenia when compared to rural living. Exposure to green space has been associated with better mental health outcomes and, more recently, childhood exposure
R. Mota Freitas, M.T. Valadas
doaj   +1 more source

Drug-induced metabolic syndrome hasn’t associations with 5-HT receptor genes polymorphisms in patients with schizophrenia

European Psychiatry, 2021
Introduction Metabolic disturbances are common in patients maintained on neuroleptics. These abnormalities significantly increase the physical comorbidity and mortality rates due to cardiovascular disease.
D. Paderina, I. Pozhidaev, A. Bocharova, E. Kornetova, A. Boiko   +4 more
doaj   +1 more source